Skip to main content
Fig. 6 | BMC Infectious Diseases

Fig. 6

From: Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis

Fig. 6

The forest plot of studies reporting 1-month mortality grouped by route of administration. Studies were ranked according to their effect sizes. # Ampicillin–sulbactam was used in non-polymyxins group. *Trimethoprim-sulfamethoxazole was used in non-polymyxins group

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us